IDL Diagnostics AB (publ)

kr 0.33As of Sun 8 Nov 2026, 12:00 UTC
STO:IDLDXHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (26.03%)
Div yield —
ROE (2.06%)
Diagnostics & Research
Beta (5Y) 0.99
PE TTM —
TSR TTM (8.59%)
Mkt cap kr 76.02M
ROIC (1.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.328
(0.49%)
(4.45%)
Hold 1|3|10|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
34.56%
42.16%
23.77%
10.38%
Revenuekr M
3.391
3.537
3.572
3.474
0.49%
2.11%
2.41%
0.77%
Peers (US$7.686M)
Cap (US$)
PE
16.27M
—
Capital
TTM
5Y
10Y
Leveragex
1.531
0.941
0.837
EBIT/Intx
2.703
0.105
0.086
Own earn%
39.62
(35.71)
(42.49)
Sh yield%
27.25
30.72
32.61
Owners
Insiders/Inst%
4.41
69.07
Short interest%
4.34
SBC / revenue%
4.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
0–12
$1 testx
—
Incr. ROIC%
2